Association of Biomarkers with Serious Cardiac Adverse Events during Abiraterone Acetate Treatment in Castration Resistant Prostate Cancer

BACKGROUND: Abiraterone acetate is an effective drug for castration-resistant prostate cancer, but cardiac serious adverse events (SAEs) may occur. We studied their association with N-terminal pro–brain natriuretic peptide (NT-proBNP) and troponin T (TnT) during abiraterone therapy. PATIENTS AND MET...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Oncol
Autors principals: Campora, Sara, Campazzi, Eleonora, Zanardi, Silvia, Puntoni, Matteo, Piccininno, Marco, Piccardo, Arnoldo, Shoushtari Zadeh Naseri, Mehrdad, Defferrari, Carlotta, Provinciali, Nicoletta, Petrera, Marilena, Marra, Domenico, Biscaldi, Ennio, Antonucci, Gian Carlo, Ricci, Damiano, Clavarezza, Matteo, Gennari, Alessandra, Gozza, Alberto, D'Amico, Mauro, Mori, Marco, DeCensi, Andrea
Format: Artigo
Idioma:Inglês
Publicat: Neoplasia Press 2016
Matèries:
Review article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5143350/
https://ncbi.nlm.nih.gov/pubmed/27916295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2016.08.001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars